Navigation Links
The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology
Date:12/2/2008

ST. JOSEPH, Mich., Dec. 2 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Burnham has become a certified GeneGo Center of Excellence. Burnham researchers will have institution-wide access to GeneGo's MetaCore data analysis suite, training and advanced support. The Burnham institute is a world-class biomedical research facility running multiple OMICs experimental studies throughout many departments, including research in cancer, stem cells, and neurobiology. MetaCore will provide a central data repository, management and collaboration platform integrated with a manually curated knowledge base and tools for seamless analyses of these studies.

"Burnham is in our backyard and we are very pleased to welcome them as a new GeneGo customer and Center of Excellence," said Julie Bryant, GeneGo's VP of Business development. "Stem cells, chemical biology, and disease specific pathway analysis platforms are among our research priorities and we are looking forward to a long term productive partnership."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.1(TM), assists pharmaceutical scientists in the areas of target selection and validation, '/>"/>

SOURCE GeneGo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cyntellect to Collaborate With the Burnham Institute for Medical Research
2. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
3. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
4. Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval
5. Canary Foundations Dr. Sanjiv Sam Gambhir Elected to the National Academies Institute of Medicine
6. BioInnovation Institute in Akron Launched
7. Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility
8. David H. Murdock Research Institute Taps Waters for Laboratory Technology
9. Dr. Larry Corey Named New Member of the Institutes of Medicine
10. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
11. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):The pitch of blue whale songs is declining around the world, scientists discover 2The pitch of blue whale songs is declining around the world, scientists discover 3Newly discovered mechanism allows cells to change state 2More than fish bait: Worms unlock secrets to new epilepsy treatments 2WaferGen Adds Robert Coradini Former President of J 26amp 3BJ New Ventures to Board of Directors 60222 1WaferGen Adds Robert Coradini Former President of J 26amp 3BJ New Ventures to Board of Directors 60222 2WaferGen Adds Robert Coradini Former President of J 26amp 3BJ New Ventures to Board of Directors 60222 3PDL BioPharma Announces Pricing of 24300 000 000 Securitization Transaction 14632 1PDL BioPharma Announces Pricing of 24300 000 000 Securitization Transaction 14632 2PDL BioPharma Announces Pricing of 24300 000 000 Securitization Transaction 14632 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5